The Supreme Cannabis Company, Inc. (TSX: FIRE) is readying itself for Canada’s “legalization 2.0” by entering into a definitive agreement with the private company Truverra Inc.
The deal is expected to be valued at around CA$20 million ($15.3 million).
Why It Matters
The acquisition of Truverra gives Supreme further access to the Canadian and international markets through Truverra’s Canadian Clinical Cannabinoids Inc. (CCC) subsidiary, the company said in a Wednesday press release.
This includes CCC’s 5,000-square-foot …